Evidence map›Paper›PMID 32917868›Full record

ArticleNature communications2020

Predicting the frequencies of drug side effects.

Diego Galeano, Shantao Li, Mark Gerstein, Alberto Paccanaro

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. A linear interpretable model for drug target prediction.Bioinformatics (Oxford, England) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Host centric drug repurposing for viral diseases.PLoS computational biology · 2025
    Article
  19. Precision Adverse Drug Reactions Prediction with Heterogeneous Graph Neural Network.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Diego GaleanoDepartment of Computer Science, Centre for Systems and Synthetic Biology, Royal Holloway, University of London, Egham Hill, Egham, UK.ORCID http://orcid.org/0000-0002-1748-7148
Shantao LiDepartment of Computer Science and Department of Biomedical Data Sciences, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-5440-2780
Mark GersteinDepartment of Molecular Biophysics and Biochemistry, Department of Computer Science, and Department of Statistics and Data Science, Yale University, New Haven, CT, 06520, USA.
Alberto PaccanaroDepartment of Computer Science, Centre for Systems and Synthetic Biology, Royal Holloway, University of London, Egham Hill, Egham, UK. alberto.paccanaro@rhul.ac.uk.ORCID http://orcid.org/0000-0001-8059-1346

Funding

Biotechnology and Biological Sciences Research Council BB/F00964X/1Biotechnology and Biological Sciences Research Council BB/K004131/1Biotechnology and Biological Sciences Research Council BB/M025047/1
6 · The paper itself

Abstract

A central issue in drug risk-benefit assessment is identifying frequencies of side effects in humans. Currently, frequencies are experimentally determined in randomised controlled clinical trials. We present a machine learning framework for computationally predicting frequencies of drug side effects. Our matrix decomposition algorithm learns latent signatures of drugs and side effects that are both reproducible and biologically interpretable. We show the usefulness of our approach on 759 structurally and therapeutically diverse drugs and 994 side effects from all human physiological systems. Our approach can be applied to any drug for which a small number of side effect frequencies have been identified, in order to predict the frequencies of further, yet unidentified, side effects. We show that our model is informative of the biology underlying drug activity: individual components of the drug signatures are related to the distinct anatomical categories of the drugs and to the specific drug routes of administration.

Indexed as

Drug-Related Side Effects and Adverse ReactionsMachine LearningAlgorithmsComputational BiologyDatabases, PharmaceuticalHumansPharmaceutical PreparationsProbabilityPharmaceutical Preparations

Identifiers

PMID32917868
PMCPMC7486409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.